Exelixis (EXEL) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $56.04 --0%
EPS Growth %: +12.0%
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: +12.0%
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.28, $0.09 better than the analyst estimate of $0.19. Revenue for the quarter came in at $419.4 million versus the consensus estimate of $390.44 million.
GUIDANCE:
Exelixis sees FY2022 revenue of $1.53-1.63 billion, versus the consensus of $1.59 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Exelixis (EXEL) PT Raised to $49 at Wells Fargo
- Rosenblatt Reiterates Neutral Rating on Netflix (NFLX) Ahead of Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
